Cambridge Trust CO Indaptus Therapeutics, Inc. Transaction History

Cambridge Trust CO

  • $2.6 Billion
  • Q1 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 16, 2022
SELL
$1.94 - $4.02 $91 - $188
-47 Closed
0 $0
Q1 2022

May 12, 2022
BUY
$3.19 - $6.17 $149 - $289
47 New
47 $0

Others Institutions Holding INDP

# of Institutions
18
Shares Held
588K
Call Options Held
0
Put Options Held
0
View Full List

About Indaptus Therapeutics, Inc.

INDP Quotes by TradingView
  • Ticker INDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 8,258,600
  • Market Cap $17.5M
  • Description
  • Indaptus Therapeutics, Inc., a pre-clinical biotechnology company, develops various anti-cancer and anti-viral immunotherapy products. Its lead clinical oncology candidate is Decoy20 to single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, as well as hepatitis B v...
More about INDP
Track This Portfolio

Track Cambridge Trust CO Portfolio

Follow Cambridge Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Trust CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email